Anticancer effects of oleuropein

BioFactors

Volumn 43, Issue 4, 2017, Pages 517-528

  Shamshoum, Hesham ^a   Vlavcheski, Filip ^a   Tsiani, Evangelia ^a  

^a BROCK UNIVERSITY   (Canada)

Author keywords

apoptosis; cancer; cell signaling; oleuropein; olive tree; proliferation; survival

Indexed keywords

OLEUROPEIN; ANTHOCYANIN; ANTINEOPLASTIC AGENT; IRIDOID;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; COLON CANCER; DRUG STRUCTURE; DRUG SYNTHESIS; GLIOBLASTOMA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; LIVER CANCER; MESOTHELIOMA; NEUROBLASTOMA; NONHUMAN; OLIVE; OSTEOSARCOMA; PANCREAS CANCER; PLANT LEAF; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SARCOMA; SKIN CANCER; THYROID CANCER; TONGUE CANCER; ANIMAL; APOPTOSIS; CELL PROLIFERATION; DRUG EFFECTS; METABOLISM; OBESITY; TUMOR CELL LINE;

ANIMALS; ANTHOCYANINS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; IRIDOIDS; OBESITY;

EID: 85020709787     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1366     Document Type: Review

References (85)

1. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646–674. Mar 4
2. Mitsudomi, T., and Yatabe, Y. (2010) Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J. 277, 301–308. Jan 1
3. (1998) Phosphoinositide kinases. Annu. Rev. Biochem. 67, 481–507.
4. Vivanco, I., and Sawyers, C. L. (2002) The phosphatidylinositol 3-Kinase–AKT pathway in human cancer. Nat. Rev. Cancer 2, 489–501. Jul
5. Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., and Mills, G. B. (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 4, 988–1004. Dec
6. Liu, P., Cheng, H., Roberts, T. M., and Zhao, J. J. (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat. Rev. Drug Discov. 8, 627–644. Aug
7. Xie, Y., Naizabekov, S., Chen, Z., and Tokay, T. (2016) Power of PTEN/AKT: molecular switch between tumor suppressors and oncogenes. Oncol. Lett. 12, 375–378. Jul
8. Bos, J. L. (1989) ras oncogenes in human cancer: a review. Cancer Res. 49, 4682–4689. Sep 1
9. Sebolt-Leopold, J. S., and Herrera, R. (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev. Cancer 4, 937–947. Dec
10. Karnoub, A. E., and Weinberg, R. A. (2008) Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol. 9, 517–531. Jul
11. Shaw, R. J., and Cantley, L. C. (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441, 424–430. May 25
12. Sabatini, D. M. (2006) mTOR and cancer: insights into a complex relationship. Nat. Rev. Cancer 6, 729–734. Sep
13. Kastan, M. B., and Bartek, J. (2004) Cell-cycle checkpoints and cancer. Nature 432, 316–323. Nov 18
14. Oren, M. (2003) Decision making by p53: life, death and cancer. Cell Death Differ. 10, 431–442. Apr
15. Laptenko, O., and Prives, C. (2006) Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ. 13, 951–961. Mar 31
16. Whibley, C., Pharoah, P. D. P., and Hollstein, M. (2009) p53 polymorphisms: cancer implications. Nat. Rev. Cancer 9, 95–107. Feb
17. Ferraiuolo, M., Di Agostino, S., Blandino, G., and Strano, S. (2016) Oncogenic intra-p53 family member interactions in human cancers. Front. Oncol. 6, 77.
18. Shieh, S. Y., Ikeda, M., Taya, Y., and Prives, C. (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325–334. Oct 31
19. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., et al. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479–489. Nov 14
20. Adams, J., and Cory, S. (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26, 1324–1337. Feb 26
21. Psaltopoulou, T., Kosti, R. I., Haidopoulos, D., Dimopoulos, M., and Panagiotakos, D. B. (2011) Olive oil intake is inversely related to cancer prevalence: a systematic review and a meta-analysis of 13,800 patients and 23,340 controls in 19 observational studies. Lipids Health Dis. 10, 127.
22. Pelucchi, C., Bosetti, C., Negri, E., Lipworth, L., and La Vecchia, C. (2011) Olive oil and cancer risk: an update of epidemiological findings through 2010. Curr. Pharm. Des. 17, 805–812.
23. Schwingshackl, L., and Hoffmann, G. (2016) Does a Mediterranean-type diet reduce cancer risk?. Curr. Nutr. Rep. 5, 9–17.
24. Servili, M., Esposto, S., Fabiani, R., Urbani, S., Taticchi, A., et al. (2009) Phenolic compounds in olive oil: antioxidant, health and organoleptic activities according to their chemical structure. Inflammopharmacology 76.
25. Servili, M., and Montedoro, G. (2002) Contribution of phenolic compounds to virgin olive oil quality. Eur. J. Lipid Sci. Technol. 104, 602–613. Oct 1
26. Soler-Rivas, C., Espín, J. C., and Wichers, H. J. (2000) Oleuropein and related compounds. J. Sci. Food Agric. 80, 1013–1023. May 15
27. Alagna, F., Geu-Flores, F., Kries, H., Panara, F., Baldoni, L., et al. (2016) Identification and characterization of the iridoid synthase involved in oleuropein biosynthesis in olive (Olea europaea) fruits. J. Biol. Chem. 291, 5542–5554. Mar 11
28. Damtoft, S., Franzyk, H., and Jensen, S. R. (1993) Biosynthesis of secoiridoid glucosides in oleaceae. Phytochemistry 34, 1291–1299. Nov 1
29. Servili, M., Baldioli, M., Selvaggini, R., Macchioni, A., and Montedoro, G. (1999) Phenolic compounds of olive fruit: one- and two-dimensional nuclear magnetic resonance characterization of nüzhenide and its distribution in the constitutive parts of fruit. J. Agric. Food Chem. 47, 12–18. Jan 1
30. Omar, S. H. (2010) Oleuropein in olive and its pharmacological effects. Sci. Pharm. 78, 133–154.
31. Fabiani, R., Rosignoli, P., De Bartolomeo, A., Fuccelli, R., Servili, M., et al. (2008) Oxidative DNA damage is prevented by extracts of olive oil, hydroxytyrosol, and other olive phenolic compounds in human blood mononuclear cells and HL60 cells. J. Nutr. 138, 1411–1416. Aug
32. Buckland, G., and Gonzalez, C. A. (2015) The role of olive oil in disease prevention: a focus on the recent epidemiological evidence from cohort studies and dietary intervention trials. Br. J. Nutr. 113, S94–101. Apr
33. Hashmi, M. A., Khan, A., Hanif, M., Farooq, U., Perveen, S., et al. (2015) Traditional uses, phytochemistry, and pharmacology of Olea europaea (olive). Evid Based Complement Altern. Med. 2015, e541591. Feb 23;2015
34. Piroddi, M., Albini, A., Fabiani, R., Giovannelli, L., Luceri, C., et al. (2016) Nutrigenomics of extra-virgin olive oil: a review. BioFactors Oxf. Engl.
35. Fabiani, R. (2016) Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies. Food Funct. 7, 4145–4159. Oct 12
36. Siegel, R. L., Miller, K. D., and Jemal, A. (2016) Cancer statistics, 2016. CA Cancer J. Clin. 66, 7–30. Jan 1
37. Evan, G. I., and Vousden, K. H. (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342–348. May 17
38. Hon, J. D. C., Singh, B., Sahin, A., Du, G., Wang, J., et al. (2016) Breast cancer molecular subtypes: from TNBC to QNBC. Am. J. Cancer. Res. 6, 1864–1872.
39. Jiang, H., and Rugo, H. S. (2015) Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options. Ther. Adv. Med. Oncol. 7, 321–339. Nov
40. Menendez, J. A., Vazquez-Martin, A., Colomer, R., Brunet, J., Carrasco-Pancorbo, A., et al. (2007) Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells. BMC Cancer 7, 80. May 9
41. Menendez, J. A., Vazquez-Martin, A., Garcia-Villalba, R., Carrasco-Pancorbo, A., Oliveras-Ferraros, C., et al. (2008) tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO). BMC Cancer 8, 377.
42. Menendez, J. A., Vazquez-Martin, A., Oliveras-Ferraros, C., Garcia-Villalba, R., Carrasco-Pancorbo, A., et al. (2008) Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays. Int. J. Mol. Med. 22, 433–439. Oct
43. Han, J., Talorete, T. P. N., Yamada, P., and Isoda, H. (2009) Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells. Cytotechnology 59, 45–53. Jan
44. Sirianni, R., Chimento, A., De Luca, A., Casaburi, I., Rizza, P., et al. (2010) Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation. Mol. Nutr. Food Res. 54, 833–840. Jun
45. Elamin, M. H., Daghestani, M. H., Omer, S. A., Elobeid, M. A., Virk, P., et al. (2013) Olive oil oleuropein has anti-breast cancer properties with higher efficiency on ER-negative cells. Food Chem. Toxicol. 53, 310–316. Mar
46. Hassan, Z. K., Elamin, M. H., Omer, S. A., Daghestani, M. H., Al-Olayan, E. S., et al. (2014) Oleuropein induces apoptosis via the p53 pathway in breast cancer cells. Asian Pac. J. Cancer Prev. 14, 6739–6742. Jan
47. Hassan, Z. K., Elamin, M. H., Daghestani, M. H., Omer, S. A., Al-Olayan, E. M., et al. (2012) Oleuropein induces anti-metastatic effects in breast cancer. Asian Pac. J. Cancer Prev. 13, 4555–4559.
48. Chimento, A., Casaburi, I., Rosano, C., Avena, P., Luca, A. d., et al. (2014) Oleuropein and hydroxytyrosol activate GPER/GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells. Mol. Nutr. Food Res. 58, 478–489. Jan 1
49. Tang, D., Wu, D., Hirao, A., Lahti, J. M., Liu, L., et al. (2002) ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J. Biol. Chem. 277, 12710–12717. Apr 12
50. Cagnol, S., and Chambard, J.-C. (2010) ERK and cell death: mechanisms of ERK-induced cell death – apoptosis, autophagy and senescence. FEBS J. 277, 2–21. Jan 1
51. Tsai, C.-W., Lin, C.-Y., and Wang, Y.-J. (2011) Carnosic acid induces the NAD(P)H: quinone oxidoreductase 1 expression in rat clone 9 cells through the p38/nuclear factor erythroid-2 related factor 2 pathway. J. Nutr. 141, 2119–2125. Dec
52. Kar, S., Palit, S., Ball, W. B., and Das, P. K. (2012) Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells. Apoptosis Int. J. Program Cell Death 17, 735–747. Jul
53. Notarnicola, M., Pisanti, S., Tutino, V., Bocale, D., Rotelli, M. T., et al. (2011) Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. Genes Nutr. 6, 63–69. Feb
54. Fernández-Arroyo, S., Gómez-Martínez, A., Rocamora-Reverte, L., Quirantes-Piné, R., Segura-Carretero, A., et al. (2012) Application of nanoLC-ESI-TOF-MS for the metabolomic analysis of phenolic compounds from extra-virgin olive oil in treated colon-cancer cells. J. Pharm. Biomed. Anal. 63, 128–134. Apr 7
55. Cárdeno, A., Sánchez-Hidalgo, M., Rosillo, M. A., and Alarcón de la Lastra, C. (2013) Oleuropein, a secoiridoid derived from olive tree, inhibits the proliferation of human colorectal cancer cell through downregulation of HIF-1α. Nutr. Cancer 65, 147–156.
56. Yan, C.-M., Chai, E.-Q., Cai, H.-Y., Miao, G.-Y., and Ma, W. (2015) Oleuropein induces apoptosis via activation of caspases and suppression of phosphatidylinositol 3-kinase/protein kinase B pathway in HepG2 human hepatoma cell line. Mol. Med. Rep. 11, 4617–4624. Jun
57. Acquaviva, R., Di Giacomo, C., Sorrenti, V., Galvano, F., Santangelo, R., et al. (2012) Antiproliferative effect of oleuropein in prostate cell lines. Int. J. Oncol. 41, 31–38. Jul
58. Goldsmith, C. D., Vuong, Q. V., Sadeqzadeh, E., Stathopoulos, C. E., and Roach, P. D. (2015) Phytochemical properties and anti-proliferative activity of Olea europaea L. leaf extracts against pancreatic cancer cells. Mol. Basel Switz. 20, 12992–13004.
59. Bulotta, S., Corradino, R., Celano, M., Maiuolo, J., D'Agostino, M., et al. (2013) Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells. J. Mol. Endocrinol. 51, 181–189.
60. Morana, J. M., Leal-Hernande, O., Canal-Macías, M. L., Roncero-Martin, R., Guerrero-Bonmatty, R., et al. (2016) Antiproliferative properties of oleuropein in human osteosarcoma cells. Nat. Prod. Commun. 11, 491–492. Apr
61. Anter, J., Fernández-Bedmar, Z., Villatoro-Pulido, M., Demyda-Peyras, S., Moreno-Millán, M., et al. (2011) A pilot study on the DNA-protective, cytotoxic, and apoptosis-inducing properties of olive-leaf extracts. Mutat. Res. 723, 165–170. Aug 16
62. Seçme, M., Eroğlu, C., Dodurga, Y., and Bağcı, G. (2016) Investigation of anticancer mechanism of oleuropein via cell cycle and apoptotic pathways in SH-SY5Y neuroblastoma cells. Gene 585, 93–99. Jul 1
63. Marchetti, C., Clericuzio, M., Borghesi, B., Cornara, L., Ribulla, S., et al. (2015) Oleuropein-enriched olive leaf extract affects calcium dynamics and impairs viability of malignant mesothelioma cells. Evid Based Complement Altern. Med. 2015, 908493.
64. Lamy, S., Ben Saad, A., Zgheib, A., and Annabi, B. (2016) Olive oil compounds inhibit the paracrine regulation of TNF-α-induced endothelial cell migration through reduced glioblastoma cell cyclooxygenase-2 expression. J. Nutr. Biochem. 27, 136–145. Jan
65. Sepporta, M. V., Fuccelli, R., Rosignoli, P., Ricci, G., Servili, M., et al. (2014) Oleuropein inhibits tumour growth and metastases dissemination in ovariectomised nude mice with MCF-7 human breast tumour xenografts. J. Funct. Foods 8, 269–273. May
66. Martínez-Martos, J. M., Mayas, M. D., Carrera, P., Arias de Saavedra, J. M., Sánchez-Agesta, R., et al. (2014) Phenolic compounds oleuropein and hydroxytyrosol exert differential effects on glioma development via antioxidant defense systems. J. Funct. Foods 11, 221–234.
67. Sepporta, M. V., Fuccelli, R., Rosignoli, P., Ricci, G., and Servili, M. (2016) Oleuropein prevents azoxymethane-induced colon crypt dysplasia and leukocytes DNA damage in A/J mice. J. Med. Food 19, Aug
68. Giner, E., Recio, M. C., Ríos, J. L., Cerdá-Nicolás, J. M., and Giner, R. M. (2016) Chemopreventive effect of oleuropein in colitis-associated colorectal cancer in c57bl/6 mice. Mol. Nutr. Food Res. 60, 242–255. Feb 1
69. Hamdi, H. K., and Castellon, R. (2005) Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor. Biochem. Biophys. Res. Commun. 334, 769–778. Sep 2
70. Kimura, Y., and Sumiyoshi, M. (2009) Olive leaf extract and its main component oleuropein prevent chronic ultraviolet B radiation-induced skin damage and carcinogenesis in hairless mice. J. Nutr. 139, 2079–2086. Nov
71. Sumiyoshi, M., and Kimura, Y. (2010) Effects of olive leaf extract and its main component oleuroepin on acute ultraviolet B irradiation-induced skin changes in C57BL/6J mice. Phytother. Res. 24, 995–1003. Jul
72. Grawish, M., Zyada, M., and Zaher, A. (2011) Inhibition of 4-NQO-induced F433 rat tongue carcinogenesis by oleuropein-rich extract. Med. Oncol. 28, 1163–1168.
73. Fabiani, R., De Bartolomeo, A., Rosignoli, P., Servili, M., and Montedoro, G. F. (2002) Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil through G1 cell cycle arrest and apoptosis. Eur. J. Cancer Prev. 11, 351–358. Aug
74. Luo, C., Li, Y., Wang, H., Cui, Y., Feng, Z., et al. (2013) Hydroxytyrosol promotes superoxide production and defects in autophagy leading to anti-proliferation and apoptosis on human prostate cancer cells. Curr. Cancer Drug Targets 13, 625–639. Jul
75. Goulas, V., Exarchou, V., Troganis, A. N., Psomiadou, E., Fotsis, T., et al. (2009) Phytochemicals in olive-leaf extracts and their antiproliferative activity against cancer and endothelial cells. Mol. Nutr. Food Res. 53, 600–608. May
76. Corona, G., Deiana, M., Incani, A., Vauzour, D., and Dessì, M. A. (2009) Hydroxytyrosol inhibits the proliferation of human colon adenocarcinoma cells through inhibition of ERK1/2 and cyclin D1. Mol. Nutr. Food Res. 53, 897–903. Jul
77. Li, S., Han, Z., Ma, Y., Song, R., Pei, T., et al. (2014) Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: an in vivo and in vitro study. Oncol. Rep. 31, 145–152. Jan
78. Terzuoli, E., Donnini, S., Giachetti, A., Iñiguez, M. A., Fresno, M., et al. (2010) Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis. Clin. Cancer Res. 16, 4207–4216. Aug 15
79. Granados-Principal, S., Quiles, J. L., Ramirez-Tortosa, C., Camacho-Corencia, P., Sanchez-Rovira, P., et al. (2011) Hydroxytyrosol inhibits growth and cell proliferation and promotes high expression of sfrp4 in rat mammary tumours. Mol. Nutr. Food Res. 55, S117–S126. May
80. de Bock, M., Thorstensen, E. B., Derraik, J. G. B., Henderson, H. V., and Hofman, P. L. (2013) Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extract. Mol. Nutr. Food Res. 57, 2079–2085. Nov
81. Schwingshackl, L., and Hoffmann, G. (2015) Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis of observational studies. Cancer Med. 4, 1933–1947. Dec
82. Binder, C., Binder, L., Marx, D., Schauer, A., and Hiddemann, W. (1997) Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues. Anticancer Res. 17, 4299–4304. Dec
83. Barron, C. C., Bilan, P. J., Tsakiridis, T., and Tsiani, E. (2016) Facilitative glucose transporters: implications for cancer detection, prognosis and treatment. Metabolism 65, 124–139. Feb
84. Bulotta, S., Celano, M., Lepore, S. M., Montalcini, T., and Pujia, A. (2014) Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases. J. Transl. Med. 12, 219.
85. O'Donnell-Tormey, J., Nathan, C. F., Lanks, K., DeBoer, C. J., and Harpe, J. d l. (1987) Secretion of pyruvate. An antioxidant defense of mammalian cells. J. Exp. Med. 165, 500–514. Feb 1